244 related articles for article (PubMed ID: 27351871)
1. The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.
Morio R; Hyogo H; Hatooka M; Morio K; Kan H; Kobayashi T; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Masayasu Y; Chayama K
J Gastroenterol; 2017 Feb; 52(2):253-262. PubMed ID: 27351871
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.
Oki Y; Ono M; Hyogo H; Ochi T; Munekage K; Nozaki Y; Hirose A; Masuda K; Mizuta H; Okamoto N; Saibara T
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):797-805. PubMed ID: 29634665
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
5. Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease.
Manchanayake J; Chitturi S; Nolan C; Farrell GC
J Gastroenterol Hepatol; 2011 Mar; 26(3):510-6. PubMed ID: 21155882
[TBL] [Abstract][Full Text] [Related]
6. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
7. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy.
Khaleeli AA; Johnson JN; Taylor WH
Diabetes Metab Res Rev; 2007 Jan; 23(1):43-8. PubMed ID: 16703622
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for increased risk of diabetes in chronic liver diseases.
Svegliati-Baroni G; Gaggini M; Carli F; Barbieri C; Cucco M; Youne R; Rosso C; Bugianesi E; Gastaldelli A
Liver Int; 2020 Oct; 40(10):2489-2499. PubMed ID: 32515880
[TBL] [Abstract][Full Text] [Related]
10. [Different prevalence of impaired glucose tolerance between hyperinsulinemic and normoinsulinemic subjects].
Xiao J; Tian H; Li CL; Zhong WW; Sun BR; Li YP; Fang FS; Han XF; Liu YQ; Cheng XL
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):299-303. PubMed ID: 22781951
[TBL] [Abstract][Full Text] [Related]
11. Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.
Miyake T; Kumagi T; Hirooka M; Furukawa S; Yoshida O; Koizumi M; Yamamoto S; Watanabe T; Yamamoto Y; Tokumoto Y; Takeshita E; Abe M; Kitai K; Matsuura B; Hiasa Y
J Gastroenterol; 2016 Nov; 51(11):1090-1100. PubMed ID: 26971094
[TBL] [Abstract][Full Text] [Related]
12. Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.
Enooku K; Kondo M; Fujiwara N; Sasako T; Shibahara J; Kado A; Okushin K; Fujinaga H; Tsutsumi T; Nakagomi R; Minami T; Sato M; Nakagawa H; Kondo Y; Asaoka Y; Tateishi R; Ueki K; Ikeda H; Yoshida H; Moriya K; Yotsuyanagi H; Kadowaki T; Fukayama M; Koike K
J Gastroenterol; 2018 Dec; 53(12):1261-1275. PubMed ID: 29749571
[TBL] [Abstract][Full Text] [Related]
13. [The clinical characteristics and trend of conversion to type 2 diabetes mellitus of individuals with normal glucose tolerance-hyperinsulinemia].
Fang FS; Tian H; Li CL; Shao YH; Li J; Zhong WW; Liu MY; Yan ST; Yang G; Cheng XL; Ma Q; Wang HX
Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):480-3. PubMed ID: 20979733
[TBL] [Abstract][Full Text] [Related]
14. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for regression from impaired glucose tolerance to normal glucose regulation in Japanese patients with nonalcoholic fatty liver disease.
Ogata C; Ohmoto-Sekine Y; Tanabe M; Iwao A; Hsieh SD; Amakawa K; Matsumoto N; Ogawa K; Arimoto S; Okuda C; Shiba M; Kato H; Hashimoto M; Ishihara M; Tsuji H; Hara S; Arase Y
Intern Med; 2014; 53(13):1401-6. PubMed ID: 24990331
[TBL] [Abstract][Full Text] [Related]
16. Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.
Junker AE; Gluud L; Holst JJ; Knop FK; Vilsbøll T
J Intern Med; 2016 May; 279(5):485-93. PubMed ID: 26728692
[TBL] [Abstract][Full Text] [Related]
17. Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease.
Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI
Liver Int; 2009 Apr; 29(4):525-9. PubMed ID: 19323780
[TBL] [Abstract][Full Text] [Related]
18. Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone.
Chai SY; Pan XY; Song KX; Huang YY; Li F; Cheng XY; Qu S
Lipids Health Dis; 2014 Jan; 13():7. PubMed ID: 24397589
[TBL] [Abstract][Full Text] [Related]
19. Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus.
Kimura Y; Hyogo H; Ishitobi T; Nabeshima Y; Arihiro K; Chayama K
J Gastroenterol Hepatol; 2011 Mar; 26(3):517-22. PubMed ID: 21054523
[TBL] [Abstract][Full Text] [Related]
20. Progression from impaired glucose tolerance to type 2 diabetes in obese children and adolescents: a 3-6-year cohort study in southern Thailand.
Jaruratanasirikul S; Thammaratchuchai S; Puwanant M; Mo-Suwan L; Sriplung H
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1267-1275. PubMed ID: 27740930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
